An international team of researchers has designed and synthetised a nanometer-scale DNA "machine" whose customised modifications enable it to recognise a specific target antibody.
The new approach may revolutionise the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV, researchers said.
The binding of the antibody to the DNA machine causes a structural change (or switch), which generates a light signal.
"One of the advantages of our approach is that it is highly versatile," said senior co-author of the study Professor Francesco Ricci, of the University of Rome, Tor Vergata.
"This DNA nanomachine can be in fact custom-modified so that it can detect a huge range of antibodies, this makes our platform adaptable for many different diseases," Ricci said.
"Our modular platform provides significant advantages over existing methods for the detection of antibodies," added Professor Vallee-Belisle of the University of Montreal, the other senior co-author of the paper.
"Another nice feature of our this platform is its low-cost," said Professor Kevin Plaxco of the University of California, Santa Barbara.
"The materials needed for one assay cost about 15 cents, making our approach very competitive in comparison with other quantitative approaches," Plaxco said.
The research is published in the journal Angewandte Chemie.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
